Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-02T18:49:08.496Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug assays in neuropsychiatry1

Published online by Cambridge University Press:  09 July 2009

P. T. Lascelles
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 11 , Issue 4 , November 1981 , pp. 661 - 667
Copyright
Copyright © Cambridge University Press 1981

References

REFERENCES

Baldessarini, R. J. (1980). Drugs and the treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics (ed. Goodman, A. Gilman, Goodman, L. S. and Goodman, A.), pp. 391–447. Goodman & Gilman's Sixth Edition. Macmillan: New York.Google Scholar
Bellantuono, C., Reggi, V., Tognoni, G. & Garattini, S. (1980). Benzodiazepines: clinical pharmacology and therapeutic use. Drugs 19, 195–219.CrossRefGoogle ScholarPubMed
Bergling, R., Mjorndal, T., Oreland, L., Rapp, W. & Wold, S. (1975). Plasma levels and clinical effects of thioridazine and thiothixene. Journal of Clinical Pharmacology 15, 178–186.CrossRefGoogle ScholarPubMed
Bittencourt, P. R. M., Wade, P., Smith, A. T. & Richens, A. (1981). The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. British Journal of Clinical Pharmacology 12, 523–533.CrossRefGoogle ScholarPubMed
Bond, A. J., Hailey, D. M. & Lader, M. H. (1977). Plasma concentrations of benzodiazepines. British Journal of Clinical Pharmacology 4, 51–56.CrossRefGoogle ScholarPubMed
Braithwaite, R. (1980). The role of plasma level monitoring of tricyclic antidepressant drugs as an aid to treatment. In Drug Concentrations in Neuropsychiatry pp. 167–197. Ciba Foundation Symposium 74 (new series). Excerpta Medica: Amsterdam.Google Scholar
Brogden, R. N., Heel, R. C., Speight, T. M. & Avery, G. S. (1979). Nomifensine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 18, 1–24.CrossRefGoogle ScholarPubMed
Burrows, G. D. (1977). Plasma levels of tricyclics, clinical response and drug interactions. In Handbook of Studies on Depression (ed. Burrows, G. D.), pp. 173–194. Excerpta Medica: Amsterdam.CrossRefGoogle Scholar
Cooper, T. B. (1978). Plasma level monitoring of antipsychotic drugs. Clinical Pharmacokinetics 3, 14–38.CrossRefGoogle ScholarPubMed
Coppen, A., Gupta, R., Montgomery, S., Ghose, K., Bailey, J., Burns, B. & De Ridder, J. J. (1976). Mianserin hydrochloride: a novel antidepressant. British Journal of Psychiatry 129, 342–345.CrossRefGoogle ScholarPubMed
Costall, B. & Naylor, G. J. (1977). Further aspects of nomifensine pharmacology. British Journal of Clinical Pharmacology 4, 89–99.CrossRefGoogle Scholar
Crammer, J. L., Elithorn, A. C. & Lennox, R. (1980). Lithium concentrations and clinical responses. In Drug Concentrations in Neuropsychiatry, pp. 81–98. Ciba Foundation Symposium 74 (new series). Excerpta Medica: Amsterdam.Google Scholar
Creese, I. & Snyder, S. H. (1977). A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270, 180–182.CrossRefGoogle ScholarPubMed
Curry, S. H. (1974). Concentration-effect relationship with major and minor tranquillizers. Clinical Pharmacology and Therapeutics 16, 192–197.CrossRefGoogle Scholar
Dahl, S. G. & Strandjord, R. E. (1977). Pharmacokinetics of chlorpromazine after single and chronic dosage. Clinical Pharmacology and Therapeutics 21 (4), 437–448.CrossRefGoogle ScholarPubMed
Dasberg, H. H., van der Kleijn, E., Guelen, P. J. R. & van Praag, H. M. (1974). Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clinical Pharmacology and Therapeutics 15 (5), 473–483.CrossRefGoogle ScholarPubMed
Evans, L., Eadie, M. J., Penny, J., Cox, J., Price, J., Weston, M. J. & Tyrer, J. H. (1978). The relationship between the therapeutic effect and plasma level of high doses of haloperidol. In Neuropsychopharmacology, Proceedings of the 11th International Congress C.I.N.P.,Vienna (ed. Saletu, B., Berner, P. and Hollister, L.). Pergamon: Oxford.Google Scholar
Freedberg, K. A., Innis, R. B., Creese, I. & Snyder, S. H. (1979). Antischizophrenic drugs: differential plasma protein binding and therapeutic activity. Life Sciences 24, 2467–2474.CrossRefGoogle ScholarPubMed
Hanks, G. W., Magnus, R. V., Myskova, I. & Mathur, G. (1980). Antidepressants in single daily doses: studies with nomifensine. In The Royal Society of Medicine International Congress and Symposium, Series Number 25, Nomifensine (ed. Stonier, P. D. and Jenner, F. A.), pp. 87–94. Grune & Stratton: London.Google Scholar
Johnstone, E. C., Bourne, R. C., Cotes, P. M., Crow, T. J., Ferrier, I. N., Owen, F. & Robinson, J. D. (1980). Blood levels of flupenthixol in patients with acute and chronic schizophrenia. In Drug Concentrations in Neuropsychiatry, pp. 99–114. Ciba Foundation Symposium 74 (new series). Excerpta Medica: Amsterdam.Google Scholar
May, P. R. A. & Van Putten, T. (1978). Plasma levels of chlorpromazine in schizophrenia: a critical review of the literature. Archives of General Psychiatry 35, 1081–1087.CrossRefGoogle ScholarPubMed
Montgomery, S., McAuley, R. & Montgomery, D. B. (1978). Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens. British Journal of Clinical Pharmacology 5,71S–76S.CrossRefGoogle Scholar
Morselli, P. L. & Zarifian, E. (1980). Clinical significance of monitoring plasma levels of psychotropic drugs. In Drug Concentrations in Neuropsychiatry, pp. 115–139. Ciba Foundation Symposium 74 (new series). Excerpta Medica: Amsterdam.Google Scholar
Nawishy, S., Trimble, M. R. & Richens, A. (1980). Antidepressants and epilepsy: the place of nomifensine. The Royal Society of Medicine International Congress and Symposium, Series Number 25, Nomifensine (ed. Stonier, P. D. and Jenner, F. A.), pp. 11–16. Grune & Stratton: London.Google Scholar
Nies, A., Robinson, D. S., Friedman, M. J., Green, R., Cooper, T. B., Ravaris, C. L. & Ives, J. O. (1977). Relationship between age and tricyclic antidepressant plasma levels. American Journal of Psychiatry 134 (7), 790–793.Google ScholarPubMed
Peat, M. A., Chem, C. & Kopjak, L. (1979). The screening and quantitation of diazepam, flurazepam, chlordiazepoxide and their metabolites in blood and plasma by electron-capture gas chromatography and high pressure liquid chromatography. Journal of Forensic Sciences 24, 46–54.CrossRefGoogle ScholarPubMed
Perry, G. F., Fitzsimmons, B., Shapiro, L. & Irwin, P. (1978). Clinical study of mianserin, imipramine and placebo in depression: blood level and MHPG correlations. British Journal of Clinical Pharmacology 5, 35S–41S.CrossRefGoogle ScholarPubMed
Pinder, R. M., Brogden, R. N., Speight, T. M. & Avery, G. S. (1977). Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13, 321–352.CrossRefGoogle ScholarPubMed
Richens, A. (1976). Clinical pharmacology and medical treatment. In A Textbook of Epilepsy (ed Laidlaw, J. and Richens, A.), pp. 185–247. Churchill Livingstone: Edinburgh.Google Scholar
Rivera-Calimlin, L., Kerzner, B. & Karch, F. E. (1978). Effect of lithium on plasma chlorpromazine levels. Clinical Pharmacology and Therapeutics 23(4), 451–455.CrossRefGoogle Scholar
Robinson, D. S., Nies, A., Ravaris, C. L., Ives, J. O. & Barlett, D. (1978). Clinical pharmacology of phenelzine. Archives of General Psychiatry 35, 629–635.CrossRefGoogle ScholarPubMed
Rutherford, D. M., Okoko, A. & Tyrer, P. J. (1978). Plasma concentrations of diazepam and desmethyldiazepam during chronic diazepam therapy. British Journal of Clinical Pharmacology 6, 69–73.CrossRefGoogle ScholarPubMed
Saletu, B. & Taeuber, K. (1980). Serum levels of nomifensine and pharmacodynamics assessed by the computer-pharmaco-EEG. The Royal Society of Medicine international Congress and Symposium, Series Number 25, Nomifensine (ed Stonier, P. D. and Jenner, F. A.), pp. 31–38. Grune & Stratton: London.Google Scholar
Shader, R. I. & Greenblatt, D. J. (1980). Benzodiazepines: some aspects of their clinical pharmacology. In Drug Concentrations in Neuropsychiatry, pp. 141–155. Ciba Foundation Symposium 74 (new series). Excerpta Medica: Amsterdam.Google Scholar
Smith, R. C., Crayton, J., Dekirmenjian, H., Klass, D. & Davis, J. M. (1979). Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Archives of General Psychiatry 36, 579–584.CrossRefGoogle ScholarPubMed
Srinivasan, D. P. & Hullin, R. P. (1980). Current concepts of lithium therapy. British Journal of Hospital Medicine 24(5), 466–475.Google ScholarPubMed
Trimble, M. (1978). Non-monoamine oxidase inhibitor antidepressants and epilepsy: a review. Epilepsia 19, 241–250.CrossRefGoogle ScholarPubMed
Tune, L. E., Creese, I., DePaulo, J. R., Slavney, P. R., Coyle, J. T. & Snyder, S. H. (1980). Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia. American Journal of Psychiatry 137(2), 187–190.Google ScholarPubMed